¿ An article in the Oct. 31, 2001, issue of BioWorld Today incorrectly stated the total potential worth of the Campath arrangement between ILEX Oncology Inc. and Millennium Pharmaceuticals Inc. The correct total potential is $140 million.
¿ Officials at Johnson & Johnson Research Pty. Ltd. in Australia said they are not engaged in a collaboration with Genetronics Inc., as reported in the Oct. 29, 2001, issue of BioWorld Today. Genetronics said they are wrapping up work in a deal that ended Sept. 30.
Editor¿s Note: The changes have been made in BioWorld Online.